We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Gene Expression Profiles Define Microbial Infection

By LabMedica International staff writers
Posted on 08 Aug 2013
A molecular test distinguishes between viral and bacterial infections in children with fever by profiling the activity of genes in a blood sample.

In febrile children, it is difficult to know whether the child has a viral infection that will resolve on its own or a potentially serious bacterial infection that requires antibiotics. More...


Scientists at Washington University School of Medicine (St. Louis, MO, USA) can distinguish between viral and bacterial infections in children with fever by profiling the activity of genes in white blood cells. They studied 30 children ages two months to three years who had fevers above 38 °C, but no obvious signs of illness, like a cough or diarrhea. Twenty-two of the children were known to have viral infections based on previous extensive genomic testing that is not yet practical to use in a clinic setting, and eight others children had bacterial infections.

The investigators used a test called a gene expression microarray that could identify patterns of gene activity in white blood cells and could discriminate children with viral infections from those with bacterial infections. In addition to whole-blood and nasopharyngeal samples for virus specific polymerase chain reaction (PCR) and high-throughput sequencing, a blood sample was collected in a Tempus Blood Ribonucleic Acid (RNA) Tube (Applied Biosystems, Foster City, CA, USA; www.appliedbiosystems.com) and stored at -80 °C for subsequent gene expression analysis.


The microarray technology enabled the team to easily distinguish bacterial infections from viral infections based on distinctive patterns of gene expression. As a comparison, the scientists performed the microarray analysis on blood samples from 35 children without fever, also ages two months to three years, who were having outpatient surgery. Earlier genomic testing showed that eight of those children had viruses, even though they did not cause any symptoms.

Gregory A. Storch, MD, a professor of pediatrics and senior author of the study said, “In the kids with a virus and a fever, many genes were very active, compared with kids who had viruses and no fever, whose genes were quiet. The microarray basically tells us how a patient is reading the infection. The very active genes tell us that an infection is making a patient sick, while quiet genes tell us either there's no infection or maybe a bacterium or virus is there, but it's not causing fever or illness.” The potential benefit of using tests that measures the response of genes to get more conclusive answers to illness. This would help to ensure that antibiotics are targeted to those children who really need them. The study was published on July 15. 2013, in the Proceedings of the National Academy of Science of the United States of America (PNAS).

Related Links:

Washington University School of Medicine

Applied Biosystems



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.